Teva sees return to growth after opioid settlement, shares jump | Reuters
Three-Stock Lunch: AMD, HAS & TEVA
Kåre Schultz new CEO of Teva - Nordic Life Science – the leading Nordic life science news service
Teva made smart decision to move to us: Allergan CEO
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
Teva Pharmaceutical Will Pay Over $4 Billion in Opioid Settlement - Bloomberg
Teva Settles Arkansas Price-Fixing Case for $931K | Arkansas Business News | ArkansasBusiness.com
In The News: Teva, Superfeet, Red Wing - Footwear Insight
Teva Rockets After Hiring Former Novo Nordisk Exec As CEO | Investor's Business Daily
Teva reaches $523 million deal to settle opioid lawsuit with New York | CNN Business
Teva Pharmaceuticals found liable in New York opioid trial - BBC News
Teva Pharmaceuticals - Lixoft
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Reports Fourth Quarter and Full Year 2021 Financial Results | Business Wire
Teva to pay New York $500M for role in opioid crisis - POLITICO
Teva banks on blockbuster Austedo sales as COVID-19, Copaxone generics take their toll | Fierce Pharma
Opioid maker Teva agrees to tentative $4.25 billion deal - The Washington Post
Teva, Allergan settle roles in opioid crisis for $4.25B, $2.37B respectively - Top Class Actions
Teva CEO: Company Would Have Gone Bankrupt Without Layoffs - Business - Haaretz.com
Teva shares surge after announcing global opioid settlement
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
